Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #28,851 to #28,900.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Epitumomab cituxetan (2 revisions)
  2. Epizootic (2 revisions)
  3. Epoxide hydrolase 3 (2 revisions)
  4. Epratuzumab (2 revisions)
  5. Eprozinol (2 revisions)
  6. Epstein's syndrome (2 revisions)
  7. Eptifibatide (patient information) (2 revisions)
  8. Equagesic (2 revisions)
  9. Leptospirosis other diagnostic studies (2 revisions)
  10. Lerisetron (2 revisions)
  11. Lesch-Nyhan syndrome MRI (2 revisions)
  12. Lesch-Nyhan syndrome causes (2 revisions)
  13. Lesch-Nyhan syndrome classification (2 revisions)
  14. Lesch-Nyhan syndrome cost-effectiveness of therapy (2 revisions)
  15. Lesch-Nyhan syndrome electrocardiogram (2 revisions)
  16. Lesch-Nyhan syndrome future or investigational therapies (2 revisions)
  17. Lesch-Nyhan syndrome primary prevention (2 revisions)
  18. Lesch-Nyhan syndrome risk factors (2 revisions)
  19. Lesch-Nyhan syndrome secondary prevention (2 revisions)
  20. Lesch-Nyhan syndrome surgery (2 revisions)
  21. Lesch-Nyhan syndrome ultrasound (2 revisions)
  22. Letosteine (2 revisions)
  23. Leucine-rich repeats and iq motif containing 1 (2 revisions)
  24. Leucine rich repeat containing 15 (2 revisions)
  25. Leucine rich repeat containing 61 (2 revisions)
  26. Leucyl/cystinyl aminopeptidase (2 revisions)
  27. Leukemia echocardiography (2 revisions)
  28. Leukemia inhibitory factor receptor (2 revisions)
  29. Leukemia laboratory tests (2 revisions)
  30. Leukemia natural history (2 revisions)
  31. Leukocytosis (patient information) (2 revisions)
  32. Leukocytosis case study one (2 revisions)
  33. Leukocytosis cost-effectiveness of therapy (2 revisions)
  34. Leukocytosis epidemiology and demographics (2 revisions)
  35. Leukocytosis future or investigational therapies (2 revisions)
  36. Leukocytosis history and symptoms (2 revisions)
  37. Leukocytosis laboratory findings (2 revisions)
  38. Leukocytosis medical therapy (2 revisions)
  39. Leukocytosis natural history, complications and prognosis (2 revisions)
  40. Leukocytosis other diagnostic studies (2 revisions)
  41. Leukocytosis physical examination (2 revisions)
  42. Leukocytosis primary prevention (2 revisions)
  43. Leukocytosis risk factors (2 revisions)
  44. Leukocytosis screening (2 revisions)
  45. Leukocytosis secondary prevention (2 revisions)
  46. Leukotriene B4 (2 revisions)
  47. Leukotriene antagonist (2 revisions)
  48. Leuprolide (patient information) (2 revisions)
  49. Levallorphan (2 revisions)
  50. Levamisole (2 revisions)

View ( | ) (20 | 50 | 100 | 250 | 500)